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Mindfulness and meditation techniques have proven successful for the reduction of stress and 
improvement in general health. In addition, meditation is linked to longevity and longer telomere 
length, a proposed biomarker of human aging. Interestingly, DNA methylation changes have been 
described at specific subtelomeric regions in long-term meditators compared to controls. However, the 
molecular basis underlying these beneficial effects of meditation on human health still remains unclear. 
Here we show that DNA methylation levels, measured by the Infinium HumanMethylation450 BeadChip 
(Illumina) array, at specific subtelomeric regions containing GPR31 and SERPINB9 genes were associated 
with telomere length in long-term meditators with a strong statistical trend when correcting for multiple 
testing. Notably, age showed no association with telomere length in the group of long-term meditators. 
These results may suggest that long-term meditation could be related to epigenetic mechanisms, in 
particular gene-specific DNA methylation changes at distinct subtelomeric regions.
In recent years, the use of mindfulness and meditation techniques have been increasing in western societies 
with the aim of reducing stress and improving overall health1–4. Mindfulness-based interventions have proved 
their beneficial effect on a number of medical and psychological conditions, including depression, anxiety, and 
immune disorders5–8. In addition, it has been proposed that meditation techniques could positively affect lon-
gevity9,10. In fact, intensive meditation training has been associated with an increase in telomerase activity11 and 
longer telomere length in blood cells12–16, which is considered a candidate biomarker of human aging.
Telomeres are DNA-protein complexes that protect the end of linear chromosomes from degradation, fusion, 
or DNA repair processes17–19. Telomeres shorten with every somatic cell division because of the end replica-
tion problem19,20, but this erosion is partially compensated by the action of telomerase, an enzyme complex 
that adds TTAGGG hexanucleotide repeats to the telomeric DNA17,21. However, telomerase expression levels in 
mammalian adult cells are not sufficient to preserve the original length of telomeres, resulting in the progressive 
shortening of chromosomes throughout life20,22–24. Telomere shortening has been associated with age-related 
conditions25–28, and telomere length is hypothesized to be a biomarker of aging and age-related morbidity29–34.
In line with other reports, our group previously observed a positive relationship between meditation prac-
tice and longer telomere length in peripheral blood cells13. Moreover, in a previous work to gain insight into 
the molecular mechanisms of meditation, we profiled genome-wide DNA methylation changes in long-term 
meditators and identified a set of 64 differentially methylated regions (DMRs), corresponding to 43 genes, when 
compared to controls35. Almost half of the DMRs (48.4%) were directly linked to common human diseases, 
including neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases. Surprisingly, up to 23.4% 
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of these DMRs were found to be located at subtelomeric regions (hypergeometric test fold-enrichment = 1.3; 
p-value < 0.05). However, the importance of these epigenetic changes within the subtelomeric regions in medi-
tators remains unclear.
Increasing evidence supports the idea that epigenetic changes in subtelomeric regions may be linked to tel-
omere length. For instance, in blood cells from healthy middle-aged men it was found that CpG sites whose 
methylation level was associated with telomere length were significantly enriched at subtelomeric regions36. Most 
importantly, TET (Ten-eleven translocation) enzymes which are responsible of converting 5-methylcytosine to 
5-hydroxymethylcytosine, have been proved crucial in telomere maintenance by modulating subtelomeric meth-
ylation levels37. Additional evidence on the potential role of DNA methylation in telomere homeostasis shows that 
mouse embryonic stem cells lacking DNA methyltransferases have decreased global methylation in subtelomeric 
regions and dramatically elongated telomeres38. On the contrary, telomere shortening to a critically short length 
leads to epigenetic defects at mammalian telomeres and subtelomeres, such as decreased subtelomeric DNA 
methylation39,40.
A number of pathological conditions support the possible involvement of subtelomeric DNA methylation in 
telomere length stability. Human mutations on the DNA methyltransferase DNMT3B [OMIM, * 602900], which 
cause immunodeficiency-centromeric instability-facial anomalies syndrome 1, are associated with subtelomeric 
global hypomethylation along with accelerated telomere shortening of fibroblasts41,42. Both direct and inverse cor-
relation has been described for various types of human cancer between subtelomeric DNA methylation levels and 
telomere length43,44. To sum up, DNA methylation levels at subtelomeric regions might play a role in maintaining 
telomere length, among other mechanisms. However, the potential effect that subtelomeric DNA methylation 
levels may exert on telomere length and the underlying mechanisms remain unknown.
The aim of the present study was to better understand the relevance of subtelomeric DNA methylation changes 
in long-term meditators. To that end, we tested the association of telomere length with DNA methylation levels 
and age in long-term meditators and controls for this set of DMRs.
Results
Subjects characteristics. The general characteristics of subjects included in the study are shown in Table 1. 
Socio-demographic characteristics including age, gender, ethnicity, and BMI were equally distributed between 
groups. However, as expected, there were significant differences in the amount of practical experience of medita-
tion and also in all the psychological health-related variables referred to below (see Methods section).
Relationship between DNA methylation levels and telomere length. From our genome-wide 
DNA methylation differential analysis between long-term MMs and controls35, we selected the group of 14 DMRs 
located in subtelomeric regions, involving chromosomes 2, 4, 5, 6, 7, 8, 16, 19, and 20. We define subtelomeric 
regions as those regions at either end of each chromosome with a length of 3000 kb. We selected this subtelomeric 






(n = 17) p
Age† 49.47 (8.16) 48.59 (9.91) 50.35 (6.11) 0.536
Sex, Male‡ 24 (70.60) 11 (64.70) 13 (76.50) 0.452
Education, University‡ 18 (52.9%) 10 (58.8%) 8 (47.1%) 0.492
BMI† 24.32 (1.94) 23.73 (2.13) 24.91 (1.58) 0.078
Months of Practice† 106.47 (123.06) 0.00 (0.00) 212.94 (84.54) <0.001
MAAS† (range 1–6) 3.93 (0.60) 3.42 (0.25) 4.43 (0.38) <0.001
FFMQ observing† (range 8–40) 26.38 (2.76) 23.94 (1.03) 28.82 (1.43) <0.001
FFMQ describing† (range 8–40) 27.44 (2.06) 26.00 (1.12) 28.88 (1.76) <0.001
FFMQ acting† (range 8–40) 30.35 (2.89) 27.88 (1.50) 32.82 (1.43) <0.001
FFMQ non judging† (range 8–40) 29.29 (4.08) 26.41 (3.81) 32.18 (1.47) <0.001
FFMQ non reacting† (range 7–35) 24.00 (2.58) 22.88 (2.47) 25.12 (2.23) 0.009
HADS anxiety† (range 0–21) 1.74 (1.52) 3.06 (0.90) 0.41 (0.51) <0.001
HADS depression† (range 0–21) 2.50 (2.02) 4.12 (1.05) 0.88 (1.32) <0.001
CDRISC resilience† (range 0–100) 27.91 (3.68) 24.53 (1.59) 31.29 (1.05) <0.001
SHS happiness† (range 4–28) 23.77 (3.65) 21.00 (1.80) 26.53 (2.83) <0.001
SCS common humanity† (range 2–8) 5.00 (1.16) 4.47 (1.01) 5.53 (1.07) 0.006
SCS mindfulness† (range 2–8) 4.97 (1.53) 3.71 (0.77) 6.24 (0.90) <0.001
SCS self-kindness† (2–10) 4.88 (0.91) 4.47 (0.88) 5.29 (0.77) 0.007
SLWS satisfaction† (range 5–35) 28.15 (2.36) 26.71 (2.20) 29.59 (1.50) <0.001
AAQ-II avoidance† (range 7–49) 18.65 (4.44) 22.41 (1.58) 14.88 (2.83) <0.001
Table 1. Characteristics of study participants. Figures represent means, standard deviations (†), and the p-value 
associated with a t contrast between the control group and the meditators group, except for sex and education, 
where the figures represent frequencies and percentages (‡) and the p-value associated with a χ2 contrast. Range 
indicates the bounds of the scales for each psychological variable.
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subtelomeres have not yet been well established. This group represents 23.4% of the total DMRs (hypergeometric 
test fold-enrichment = 1.3; p-value < 0.05) that were identified in long-term MMs compared to controls. Genes 
and DNA methylation levels for these regions are shown in Table 2.
The raw differences between groups showed that telomere length was longer in meditators (Mn = 10.47; 
SD = 0.86) compared to controls (Mn = 9.87; SD = 0.94), without any statistical significance, but showing 
a strong trend (t = −1.94; df = 32; p = 0.061), with a moderately high ES (d = 0.67). However, the differences 
appeared to be significant (t = −3.44; df = 32; p = 0.002) after controlling for age, with a very high ES (d = 1.25). 
We then asked whether telomere length was correlated with gene-specific DNA methylation levels. In the group 
of long-term MMs, we found a positive raw correlation between telomere length and DNA methylation levels at 
the GPR31 gene (r = 0.58, p = 0.014), whereas an inverse correlation was shown between telomere length and 
DNA methylation levels at two distinct loci: SERPINB9 gene (r = −0.64, p = 0.006) and an intergenic CpG island 
within the subtelomeric region of chromosome 4 short arm (chr4:1514317–1514621, GRCh37/hg19 assembly) 
(r = −0.51, p = 0.036) (Fig. 1). After correction for age, the significant correlations remained (Table 3). To test for 
multiple comparisons, we draw at random 1000 sub-samples of 14 not differentially methylated regions within 
subtelomeric regions. The proportion of such random sets showing 3 or more hits with absolute r value greater 
than or equal to 0.51 (the minimum value for our selection) was 0.052 (>0.05). Therefore, the possibility of a false 
positive result cannot be completely excluded.
Maps of these DMRs and differential DNA methylation levels between long-term MMs and controls are 
shown in Fig. 2. In contrast, no significant correlation was found between DNA methylation levels of any gene 
and telomere length in the control group, either before or after controlling for age (Table 3, Fig. 1).
Relationship between age and telomere length. Since age is well known to be associated with pro-
gressive telomere shortening, we further checked the correlation between age and telomere length separately for 
each group. We found that age showed a strong inverse correlation with telomere length in the control group 
(r = −0.95, p < 0.001), as expected. In fact, the great explanatory power of multivariate models to explain tel-
omere length in the control group was exclusively due to the intervention of age (Table 3). However, this inverse 
correlation between age and telomere length, although with a moderately low effect, was no longer seen to be 
significant for the meditation group (r = −0.38, p = 0.127), in which multivariate models were less powered to 
explain telomere length, and only some DNA methylation levels showed significant contributions (Table 3).
Relationship between DNA methylation and mRNA expression. We measured GPR31 and 
SERPIN9 mRNA expression levels by real time quantitative PCR (RT-qPCR) in peripheral blood of long-term 
meditators compared to controls. Three control samples did not pass the RNA quality threshold (see Methods 
section) and so were not included in the experiments. Eventually, 17 long-term meditators were compared to 14 
controls. After normalizing mRNA expression levels to the geometric mean of 2 housekeeping genes (ACTB & 
TBP), we found that blood expression was very low for GPR31 (CTs >30), so no reliable differential analysis could 
be performed. In the case of SERPIN9, differential analysis showed no statistical significant difference in mRNA 
expression levels between meditators and controls (p = 0.493).
Gene alias Chr DMR-start DMR-end
no.
probes p-value beta.diff Genomic Location
C8orf73/MROH6 chr8 144654887 144655484 4 0,002101627 −0,057729475 1stExon,5′UTR,TSS200,TSS1500
ERICH1-AS1 chr8 709576 709692 2 0,036605753 −0,059338436
GPR31 chr6 167571172 167571803 5 0,023259942 −0,07099427 1stExon,TSS200,TSS1500
KBTBD11 chr8 1954777 1955196 4 3,90054E-08 −0,053 3′UTR
MADCAM1 chr19 495355 495737 2 0,001456746 −0,081370984 TSS1500
MLPH chr2 238406108 238406478 3 0,003007912 −0,056124149 Body
MYL5,MFSD7 chr4 675137 675827 3 0,008481849 0,126013355 Body
PRR25 chr16 857454 857863 3 0,036715428 0,106034484 Body
RPS6KA2 chr6 166876490 166877038 7 0,000731957 −0,064536785 Body
RPS6KA2 chr6 167070053 167070616 3 0,009173941 0,081025691 Body
RUFY1 chr5 178986131 178986728 7 0,029542821 −0,063294921 TSS1500,Body,TSS200
SERPINB9 chr6 2891973 2892050 2 0,00012719 0,061725435 Body
SRXN1 chr20 633418 634604 4 0,004924204 −0,062058469 Body,TSS1500
UNCX chr7 1266180 1267228 4 0,000393945 −0,114311707
Intergenic chr4 1514317 1514621 2 0,008962804 −0,086216947
Table 2. List of differentially methylated regions between long-term meditators and controls located in 
subtelomeric regions. NA = not applicable, Chr = Chromosome, DMR = differentially methylated region, DMR-
start = coordinates of the beginning of each DMR annotated by UCSC hg19 build, DMR-end = coordinates of 
the end of each DMR annotated by UCSC hg19 build, no.probes = total number of differentially methylated 
probes within each DMR, beta.diff = difference in average methylation between mindfulness-practitioners and 
controls for each DMR, UTR = untranslated region, TSS = transcription start site.
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Discussion
In this cross-sectional study, we have shown that telomere length is associated with DNA methylation levels 
in long-term MMs at three distinct subtelomeric regions, involving the GPR31 and SERPINB9 genes. Notably, 
telomere length did not correlate with age in the group of meditators, in contrast with the significant inverse 
correlation between telomere length and age in the comparison group.
Telomere length is involved in molecular and cellular senescence and has been proposed as a biomarker of 
human aging29–34. The progressive decrease in telomere length with age has long been known22–24. Short telomeres 
contribute to genomic instability that is permissive for cancer initiation and progression17. In addition, leuko-
cyte telomere shortening has been associated with several age-related conditions, such as cardiovascular events, 
including stroke and myocardial infarction25,26, and cognitive performance27. In this scenario, telomerase-based 
therapies are emerging as novel approaches for the treatment of age-related diseases45,46.
While stressful life events and psychological stress have been consistently associated with leukocyte tel-
omere erosion47–50, some healthy habits and behaviors have been related to longer telomere length or reported 
to reduce the rate of telomere shortening, e.g., physical activity and training51–53. In line with the previous fac-
tors, yoga practice and meditation are related to longer telomere length in blood cells12,14–16, as a previous work 
Figure 1. Relationships between intergenic (chr4: 1514317–1514621), GPR31, and SERPINB9 DNA 
methylation levels and telomere length, according to group. The intergenic region (chr4: 1514317–1514621) is 
in the first row, GPR31 in the second, and SERPINB9 in the third. Long-term meditators are in the first column 
and controls are in the second. Methylation levels are represented in the horizontal axis (X), and telomeres 
length in the vertical axis (Y).
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by our group has also shown13. Also in the case of cancer patients, such as distressed breast cancer survivors, 
mindfulness-based therapy is associated with telomere length maintenance54. Furthermore, it has been observed 
that mindfulness meditation leads to increased telomerase activity in PBMCs15. All this evidence suggests that 
some interventions may help to buffer the negative impact of stress on health and telomere length. A num-
ber of mechanisms have been postulated to mediate the effect of meditation on telomere stability, such as the 
modulation of the hypothalamic-pituitary-adrenal axis55 or reduction in oxidative stress and inflammatory path-
ways20,56,57. However, the biological substrate underlying this relationship remains largely unknown.
Meditators Non- Meditators
Md SD r R2 Beta R2y.12 Md SD r R2 Beta R2y.12
0.15 0.91***
Age −0.39 −0.93***
UNCX 0.592 0.135 −0.03 <0.01 0.03 0.706 0.050 −0.28 0.08 −0.11
0.41* 0.90***
Age −0.38 −0.95***
NA 0.537 0.067 −0.51* 0.26* −0.51* 0.623 0.076 0.14 0.02 0.01
0.17 0.90***
Age −0.46 −0.94***
MADCAM1 0.414 0.064 0.03 <0.01 −0.18 0.496 0.060 0.37 0.14 0.04
0.45* 0.92***
Age −0.33 −0.94***
GPR31 0.480 0.061 0.58* 0.34* 0.55* 0.551 0.072 0.19 0.04 0.14
0.15 0.90***
Age −0.39 −0.95***
RPS6KA2 0.801 0.066 0.03 <0.01 0.05 0.720 0.053 −0.02 <0.01 −0.05
0.24 0.90***
Age −0.40 −0.95***
SFXN1 0.536 0.050 0.29 0.08 0.30 0.596 0.060 0.25 0.06 0.01
0.19 0.90***
Age −0.28 −0.94***
SRXN1 0.571 0.048 0.36 0.13 0.23 0.633 0.038 −0.15 0.02 −0.03
0.23 0.92***
Age −0.42 −0.96***
ERICH1_AS1 0.668 0.065 0.25 0.06 0.29 0.727 0.040 0.04 <0.01 0.13
0.15 0.90***
Age −0.39 −0.95***
C8orf73 0.252 0.043 −0.06 <0.01 −0.06 0.310 0.070 0.08 0.01 −0.01
0.16 0.90***
Age −0.34 −0.95***
MLPH 0.725 0.043 0.25 0.06 0.11 0.782 0.028 −0.29 0.08 0.01
0.20 0.90***
Age −0.43 −0.95***
KBTBD11 0.306 0.064 0.14 0.02 0.23 0.340 0.055 0.29 0.08 −0.01
0.40* 0.90***
Age <0.01 −0.95***
SERPINB9 0.790 0.042 −0.64** 0.40** −0.64* 0.728 0.038 −0.07 0.01 −0.02
0.27 0.90***
Age −0.31 −0.95***
SSTR5 0.577 0.057 −0.43 0.18 −0.36 0.525 0.027 0.01 <0.01 0.03
0.16 0.91***
Age −0.32 −0.96***
MYL5 0.295 0.174 −0.29 0.08 −0.13 0.169 0.105 0.06 <0.01 −0.10
Table 3. Explanatory power of gene methylation on the length of long telomeres according to group. 
Md = mean. SD = standard deviation. r = Pearson’s raw correlation between telomere length and gene 
methylation. R2 = bivariate determination coefficient (dependent variable: telomere length; independent 
variable: genes methylation). R2y.12 = multiple determination coefficient (dependent variable: telomere length; 
independent variables: age and gene methylation). Beta = standardized slope when using multiple regression 
models. *p < 0.05. **p < 0.01. ***p < 0.001.
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In the present study, differences between meditators and controls on telomere length were not significant 
before controlling for age, and thus did not replicate the raw findings from Alda et al.13. However, this could 
be due to the smaller sample size used that could reduce statistical power. In fact, results of the present study 
showed a trend very close to statistical significance, with a moderately high effect size, and differences appeared 
clearer and significant after controlling for age. Anyway, as expected, our study found a strong inverse correlation 
between age and telomere length in the control group. Interestingly, we observed that age was no longer related 
to telomere length in the group of long-term MMs. Due to the limited sample size, this finding may cautiously 
be interpreted as suggesting that long-term meditation may somewhat counteract the effect of biological aging 
on telomere length. This could be accounted for, at least in part, the fact that meditation significantly reduces 
stress and the biological correlates of stress on the human body58,59. Consistent with this idea, meditation has also 
been associated with longevity60,61. Anyhow, this is an exploratory study and the underlying molecular changes 
still need further investigation. This work will guide future research using more powered designs to control for 
possible errors.
Remarkably, we also found that telomere length was associated with gene-specific subtelomeric DNA meth-
ylation changes in the group of long-term MMs. The fact that no correlation was found between the DNA meth-
ylation levels of the selected genes and the telomere length in the control group is intriguing. First, we cannot 
preclude in the controls that other genes undergo changes in DNA methylation levels in relation to telomere 
length, since we have studied a very small number of genes. Second, these genes were found to be differentially 
methylated in meditation practitioners and meditation may be related to the maintenance of telomere length12–16. 
Thus, finding a relationship between methylation of these genes and telomere length is interesting and opens up 
the venue to further study these genes as targets of epigenetic changes in meditation practitioners.
As mention above, these genomic spots were found to be differentially methylated in meditators compared 
to controls in our previous work35. In the present study, DNA methylation levels at the GPR31 gene were posi-
tively correlated to telomere length. GPR31 (G protein-coupled receptor 31) encodes a high-affinity cell mem-
brane receptor for 12-S-HETE, which is an arachidonic acid metabolite secreted by platelets and tumor cells 
that induces endothelial cell retraction and plays a role in extravasation and metastasis62. Notably, GPR31 has 
been proposed as a target of oncology therapies since GPR31 mediates KRAS (Kirsten rat sarcoma viral onco-
gene homolog) membrane association35,63, an important mechanism of tumorigenesis. More recently, GPR31 was 
reported to underlie hepatic ischemia-reperfusion injury64.
In addition, DNA methylation levels at the SERPINB9 gene were inversely related to telomere length. 
SERPINB9 (Serpin B9) encodes a member of the serine protease inhibitor family, also known as serpins. 
SERPINB9 inhibits the activity of the pro-apoptotic effector molecule granzyme B65 and therefore protects cyto-
toxic T-lymphocytes from apoptosis66. It is also expressed in accessory immune cells, such as dendritic cells, 
where it plays a role in presenting antigens67. SERPINB9 could contribute to immune evasion in leukemia cells68 
and to overcoming intracellular cytotoxicity in neuroectodermal tumors69. It has also been involved in auto-
immune diseases70, such as celiac disease71. Interestingly, SERPINB9 expression is reduced in atherosclerotic 
lesions72, and the axis SERPINB9/granzyme B has been proposed to modulate inflammation and insulin resist-
ance in coronary atherosclerosis68. A previous report found SERPINB9 to be differentially methylated in blood 
cells of patients with abdominal aortic aneurysms71. SERPINB9 involvement in inflammatory pathways makes it 
biologically plausible the reported link with telomere length since inflammation is one of the postulated mecha-
nisms to underlie the effect of meditation on improving human health33,53.
Still, the association of DNA methylation levels on those particular genes and telomere length is interesting 
even though the underlying mechanisms are far to be unraveled. It may be that these particular genes display a 
Figure 2. DNA methylation levels of differentially methylated regions (DMRs) identified in long-term 
meditators that were associated with telomere length. The upper track of each panel shows the subtelomeric 
position of mindfulness-related DMRs (human ideograms) and the genomic map of each region. Below each 
gene, white boxes denote CpG islands and black boxes represent DMRs. Dot-plot graphs show the results of the 
450 K array (beta values) for GPR31 and SERPINB9 and the intergenic region (subtelomeric region at short arm 
of chr4).
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function on the general biology of telomeres that is still not known. Further investigations on ablation or over-
expression of these genes in in vitro or in vivo models and their effect on telomere length would be of help to 
elucidate this point. On the other hand, the relationship between DNA methylation levels and mRNA expression 
levels for these genes is still not clear. For example, a report showed an inverse correlation between methylation 
and expression for SERPINB973 while a direct correlation was found in other work74. In any case, as those genes 
were differentially methylated in long-term meditators, we could hypothesize that these particular genes may 
be a biological target of meditation. However, whether those genes are definitely involved in telomere biology 
can only be investigated by other type of experiments such as silencing or overexpressing them in cell or animal 
models. As for the mechanisms by which meditation changes DNA methylation at particular genes are still far to 
be understood.
Finally, telomere length inversely correlated with DNA methylation levels at a CpG island located in the sub-
telomeric region of the short arm of chromosome 4. This result is intriguing, as this locus is a gene desert, a region 
devoid of protein-coding genes. The differentially methylated CpG island is conserved across vertebrate species 
(Fig. 3). It seems to overlap an enhancer region in human embryonic stem cells (H1-hESCs) and is only 400 bp 
apart from an insulator region conserved across different cell lines. Further research will be needed to elucidate 
the role of this subtelomeric region on influencing telomere length maintenance.
However, this study is greatly exploratory and very limited in terms of not only statistical power but also 
regarding the possibility of establishing causal relationships. Judging by the effect sizes detected, significant 
relationships between age and telomere length might be observed in meditators when using larger samples. 
Nevertheless, we have observed that the effect size of the relationship between age and telomere length was dras-
tically reduced in meditators when compared with non-meditator controls. In summary, this exploratory study 
will serve as a guide of future fully powered designs to clarify the true nature of all of these possible relationships.
conclusions
We had previously observed that differential DNA methylation changes in long-term meditators involved subtelo-
meric regions. Here, we show that DNA methylation levels at distinct subtelomeric regions encompassing GPR31 
and SERPINB9 genes are associated with telomere length only in the group of long-term meditators. However, 
we should be cautious about this result since it is above the threshold we used to correct for multiple-testing and 
therefore, it should be considered an exploratory study. In addition, age is no longer associated with telomere 
length in this group. The results of this exploratory study suggest that long-term meditation may be related to the 
age-related erosion of telomeres. Although the underlying mechanisms are not yet well understood, changes in 
DNA methylation arise as a factor that could contribute to this effect. Validation in an independent cohort would 
strengthen the results of the present study.
Methods
Participants. A group of long-term mindfulness meditators (MMs) (n = 17) was recruited from among 
members of the Spanish Association of Mindfulness and students enrolled in the Master of Mindfulness program 
at the University of Zaragoza. A comparison group of healthy controls (n = 17) was recruited from among healthy 
relatives and friends of the long-term MMs who had a similar lifestyle, and it was matched by gender, age (±2 
years) and ethnic group. All the participants were Caucasian (European ancestry). Long-term MMs were required 
Figure 3. Genomic mapping of the intergenic subtelomeric region at the short arm of chr4. The graph was 
obtained from the UCSC Genome Browser and shows genomic position of the third DMR in long-term 
meditators compared to controls that was associated with telomere length. The black box represents the DMR 
(chr4:1514317–1514621, GRCh37/hg19 assembly). The green boxes represent CpG islands. Below, predicted 
functional elements are shown for each of eighth human cell lines explored by Chromatine imunoprecipitation 
(ChIP) combined with massively parallel DNA sequencing. Boxes represent insulators (blue), promoter regions 
(red), enhancers (yellow), and weak transcribed regions (light green). This track was obtained from Chromatin 
State Segmentation by HMM from ENCODE/Broad track shown at the UCSC Genome Browser. At the bottom, 
the conserved evolutionary conservation state across vertebrate species is shown for this region. The track was 
obtained from Vertebrate Multiz Alignment & Conservation (100 Species) at the UCSC Genome Browser.
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to have practiced meditation continuously for more than 10 years before the start of the study (including the 
previous 10 years) with a mean of at least 60 min/day of formal practice during the entire period. Information on 
participants´ meditation experience was also assessed, including the number of months that the participants had 
practiced meditation throughout their lifetime. The procedure and inclusion and exclusion criteria, along with 
socio-demographic, psychological, and health-related questionnaires, have been described elsewhere35.
Telomere length measurement. From each subject, blood was obtained by venous puncture from the 
antecubital vein in sodium heparin tubes and processed within 24 h of collection to isolate peripheral blood 
mononuclear cells (PBMCs) using a Ficoll-Hypaque gradient. PBMC samples were rinsed in phosphate buffer 
solution, counted and resuspended at 10 million cells per milliliter in a freezing medium processed and stored in 
liquid nitrogen until further use. Telomere length assessment was performed as previously described13.
In brief, aliquots were thawed and diluted to plate 3.5 × 104 cells/well by quintuple in 384-well plates. Cells 
were fixed with methanol/acetic acid (3/1, v/v), treated with pepsin to digest the cytoplasm and the nuclei were 
then processed for in situ hybridization with a fluorescent Peptide Nucleic Ncid (PNA) probe that recognizes 
telomere repeats (sequence: Alexa488-OO-CCCTAACCCTAACCCTAA, Panagene). After several washing steps, 
as described by the standard DAPI incubation procedures for DNA staining, the wells were filled with mounting 
medium, and the plate was stored overnight at 4 °C.
Quantitative image acquisition and analysis were performed using the Opera High-Content Screening System 
(Perkin Elmer) with Acapella software, version 1.8 (Perkin Elmer, Waltham, MA, USA). Images were captured 
using a ×40 0.95 NA water immersion objective. UV and 488-nm excitation wavelengths were used to detect 
the DAPI and A488 signals, respectively. The results of the intensity of each foci identified were exported from 
the Acapella software (Perkin Elmer). Telomere length distribution and median telomere length were calculated 
with software from Life Length (www.lifelength.com). Samples with coefficients of variation lesser than 10% were 
accepted for the study.
DNA methylation levels and differential methylation analysis. DNA was isolated from periph-
eral blood leukocytes by standardized methods75. DNA methylation data was generated using the Infinium 
HumanMethylation450 BeadChip array (Illumina, Inc., San Diego, CA, USA) at the Roswell Park Cancer 
Institute Genomics Shared Resource (Buffalo, NY, USA). 500 ng of genomic DNA from each sample was bisulfite 
treated and hybridized onto the BeadChip according to the manufacturer’s protocol. The percentage of meth-
ylation (β value) at each interrogated CpG site was calculated after quality control and normalization steps as 
described elsewhere35. In brief, image processing was carried out using the GenomeStudio Methylation Module 
(Illumina, Inc.). Background was corrected and adjustment was performed to avoid type I/II assay chemistry bias. 
To minimize technical variation and improve data quality we used the Dasen method76 as a normalization tool. 
Before performing differential methylation analysis, we removed probes overlapping common single nucleotide 
polymorphisms (SNPs) based on NCBI dbSNP Build 137 along with those probes classified as internal controls 
of the Illumina microarray. Additionally, probes located on the X and Y chromosomes were discarded along with 
probes that hybridized to multiple locations in the genome77,78. Probes that technically did not pass the Illumina 
quality threshold (1567 probes with beadcount <3 in >5% of samples and 535 probes having 1% of samples with 
a detection p-value > 0.05) were also removed. In the end, a total of 263 495 probes (representing CpG sites) were 
analyzed for differential methylation.
Differential methylation analysis was performed to identify differentially methylated regions (DMRs), 
defined as loci containing concordant and significant changes for neighboring CpGs (≥2 CpGs)79. We applied a 
Bioconductor package, DMRcate, that detect concordant and significant changes for neighboring CpGs by a ker-
nel function to identify DMRs80. Methylation differences were prioritized by lowest p-values to ensure the most 
consistent DMRs between meditators and controls were included. These analyses identified sets of candidate loci 
with consistent differences in methylation in MM versus controls. An extended version of this section is included 
in Supplemental File 1.
Mindfulness and psychological health-related variables. The Mindful Attention Awareness Scale 
(MAAS) is a 15-item scale used to measure awareness as a dispositional characteristic of paying attention to what 
is occurring in the present moment81. We used the Spanish version of the MAAS, which has displayed the appro-
priate psychometrics, with an internal consistency of α = 0.8982.
The Five Facet Mindfulness Questionnaire (FFMQ) is a 39-item questionnaire that evaluates five compo-
nents of mindfulness: observing, describing, acting with awareness, non-judging of inner experience, and 
non-reactivity to inner experience83. The Spanish validated version of the FFMQ84, which has demonstrated ade-
quate consistency values (α ≥ 0.80 in all the facets), was used.
The Hospital Anxiety and Depression Scale (HADS) is a 14-item questionnaire used to measure anxiety and 
depression85. The validity and reliability of the Spanish version of the HADS has shown to be adequate86, with 
internal consistency values in the corresponding subscales of anxiety and depression of α = 0.84 and α = 0.85, 
respectively.
The Connor-Davidson Resilience Scale (CD-RISC) is a 10-item scale used to measure resilience, defined 
as the psychological ability to successfully cope with adversity87. We used the Spanish validated version of the 
CD-RISC88, which has shown good psychometric characteristics (α = 0.85).
The Subjective Happiness Scale (SHS) is a 4-item scale used to measure subjective global happiness89. The 
Spanish version of the SHS90 was used, which has demonstrated good validity and also appropriate reliability 
values (α = 0.72).
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The Self-Compassion Scale (SCS) is a 26-item scale that measures three facets of self-compassion (including 
negative aspects that are reverse coded): self-kindness, common humanity, and mindfulness (defined as the spe-
cific ability to keep emotions in balance when something is upsetting)91. We used the Spanish version of the SCS, 
with alpha values ranging from α = 0.72 to α = 0.7992.
The Satisfaction With Life Scale (SWLS) is a 5-item scale through which participants rate their overall sat-
isfaction with their lives93. This questionnaire has been validated in Spanish94 with good validity and reliability 
parameters (α = 0.86).
The Experiential Avoidance Questionnaire (AAQ-II) is a 7-item scale that assesses one’s unwillingness to 
experience emotions and thoughts, and the inability to be in the present and engage in valued behavior when 
unwanted emotions/thoughts are present95. The Spanish translated and validated version of the AAQ-II96, which 
has presented adequate psychometrics (α = 0.93), was used.
mRNA expression analysis by RT-qPCR. Total RNA was isolated from blood samples using RNeasy 
Lipid Tissue Mini kit (QIAGEN, Redwood City, CA, USA), following manufacturer’s instructions. Genomic DNA 
was removed with recombinant DNase (TURBO DNA-free™ Kit, Ambion, Inc., Austin, TX, USA). RNA integrity 
was checked by 1.25% agarose gel electrophoresis under denaturing conditions. Concentration and purity of RNA 
were both evaluated with NanoDrop spectrophotometer. Only RNA samples showing a minimum quality index 
(260 nm/280 nm absorbance ratios between 1.8 and 2.2 and 260 nm/230 nm absorbance ratios higher than 1.8) 
were included in the study. Complementary DNA (cDNA) was reverse transcribed from 1500 ng total RNA with 
SuperScript® III First-Strand Synthesis Reverse Transcriptase (Invitrogen, Carlsbad, CA, USA) after priming 
with oligo-d (T) and random primers. RT-qPCR reactions were performed in triplicate with Power SYBR Green 
PCR Master Mix (Invitrogen, Carlsbad, CA, USA) in a QuantStudio 12K Flex Real-Time PCR System (Applied 
Biosystems, Foster City, CA, USA). Sequences of primer pair were designed using Real Time PCR tool (IDT, 
Coralville, IA, USA). Relative expression level of genes mRNA in a particular sample was calculated as previously 
described [19] and the geometric mean of ACTB and TBP genes was used as the reference gene to normalize 
expression values.
Statistical data analysis. The socio-demographic data and psychological health-related variables were 
described using either means and standard deviations (SDs), or frequencies and percentages, depending on their 
nature. Hypergeometric test (cumulative) was used to test for DMRs enrichment in subtelomeric regions. The 
comparisons between groups (MMs and healthy controls) in these variables were performed using the corre-
sponding Student’s t and chi-squared tests. We also used the Student’s t test to compare the telomere length 
between groups, and we incorporated an ANCOVA to the same comparison to adjust for age. The effect size (ES) 
of differences was estimated by means of Cohen’s d. Values from 0.10 to 0.30 are considered to be small; from 0.31 
to 0.50 intermediate; and 0.51 and higher, strong97. The level of relationships between age and telomere length, as 
well as between telomere length and DNA methylation levels, was assessed by means of Pearson’s r correlations 
separately for each group. We also calculated multiple regression models to control for age the relationships 
between telomere length and DNA methylation. Standardized regression coefficients (beta) were used to assess 
the individual contribution of DNA methylation and age in explaining telomere length, and the Wald test was 
used to evaluate the statistical significance of influences. Determination coefficients (R2) were used to evaluate 
the raw explanatory power of DNA methylation on the telomere length, while adjusted multiple determination 
coefficients (R2y.12) were used to observe the grouped explanatory power of age and DNA methylation. Their sig-
nificance was assessed using analysis of variance. All of the tests used were bilateral, and the significance level was 
α < 0.05. As an alternative to multiple testing correction, we draw at random 1000 sub-samples of 14 not-DMRs 
and compute the proportion of such random sets that exhibit a lower number of correlations with telomere length 
(in the meditators group) than when considering the 14 meditation-related DMRs. This analysis was built with 
replacement and by using a set of 32830 non DMRs. SPSS-19 (IBM, Inc., USA) statistical software package was 
used. There were corrections for multiple comparisons but this study is of a highly exploratory nature98.
Ethics approval and consent to participate. The study was approved by the Regional Ethics Committee 
of Aragon (number PI13/0056) and was conducted in accordance with the ethical standards of the 1964 
Convention norms of Helsinki and later modifications. All of the participants provided their written informed 
consent before participating in the study.
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